Skip to content

Very Low Ketogenic Diet and Energy Expenditure

Effect of Very Low Ketogenic Diet on Energy Metabolism in Women With Obesity

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06252077
Enrollment
20
Registered
2024-02-09
Start date
2022-06-16
Completion date
2025-03-16
Last updated
2025-06-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Energy Metabolism

Brief summary

This study aimed at evaluating the effectiveness of the active phase of a very low-calorie ketogenic diet in females with obesity lasting 28 days on body weight, body composition and energy metabolism using a metabolic chamber.

Detailed description

Patients were recruited at the Obesity and Lipodystrophy Center, University Hospital of Pisa. Enrolled subjects underwent active phase of very low-calorie ketogenic diet within the metabolic chamber from day 0 for a duration of 4 weeks (day 0-28). On days 0, 7, and 28, patients underwent a 24-hour measurement of energy metabolism using the metabolic chamber. On the day of exit from the chamber measurement of body composition was conducted using total-body densitometry (Lunar iDXA; GE Healthcare).

Interventions

DIETARY_SUPPLEMENTvery low ketogenic diet

1 month of active phase of very low ketogenic diet

Sponsors

University of Pisa
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE

Intervention model description

body weight loss

Eligibility

Sex/Gender
ALL
Age
18 Years to 65 Years
Healthy volunteers
Yes

Inclusion criteria

* overweight and obesity

Exclusion criteria

* Type 1 and type 2 diabetes mellitus * endocrine disorders * asthma or pulmonary conditions * cardiovascular disease * gastrointestinal disease * liver disease * kidney diseases * anemia (hemoglobin \< 11 g/dL) * leucopenia (white blood cells \< 4,000/mcL) * thrombocytopenia (platelets \< 150,000/mcL) * central nervous system disorders * neurodegenerative diseases * psychiatric disorders * eating disorders * alcohol abuse and substance dependence * pregnancy * lactation.

Design outcomes

Primary

MeasureTime frameDescription
measure of energy expenditure1 monthmeasures of energy expenditure (in kilocalories) will be assessed by using the metabolic chamber, 24-hour whole room indirect calorimeter. Thus, the measures will be expressed in Kilocalories over 24 hours.

Countries

Italy

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026